Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Outlines Mandated eCopy Submission Program In Draft Guidance

This article was originally published in The Gray Sheet

Executive Summary

The agency issued a draft guidance listing the requirements for its eCopy submission program for medical devices. An eCopy will be mandatory for all device firms after the draft is finalized.


Related Content

FDA Finalizes 510(k), PMA, eCopy Guidances
Regulatory News In Brief
Multiple MDUFA Policies In Transition Phase Until Jan. 1
FDA Releases Guidance Documents On PMA, 510(k) Review Times And Goals
FDA Charges Ahead With MDUFA III Implementation, Despite Budget Uncertainties
Final FDA Bill: Device Provisions
CDRH Prepares For Electronic Recall Submissions; Pre-Market Still A Challenge
Mandatory Electronic Review, Voluntary E-Submissions On OIVD Horizon





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts